TNF-alpha: a link between hypertriglyceridaemia and inflammation in SLE patients with cardiovascular disease.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Lupus

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 12873047
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Plasma tumour necrosis factor-alpha and early carotid atherosclerosis in healthy middle-aged men.

  2002cited by this paper
• Significant predictors of poor prognosis in women aged ≤65 years hospitalized for an acute coronary event

  2002cited by this paper
• Drug-induced systemic lupus erythematosus associated with etanercept therapy.

  2002cited by this paper
• Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis.

  2002cited by this paper
• Severe hypertriglyceridemia with insulin resistance is associated with systemic inflammation: reversal with bezafibrate therapy in a randomized controlled trial.

  2002cited by this paper
• Risk Factors for Cardiovascular Disease in Systemic Lupus Erythematosus

  2001cited by this paper
• Endothelial cell apoptosis: biochemical characteristics and potential implications for atherosclerosis.

  2001cited by this paper
• Plasma total homocysteine levels are associated with von Willebrand factor, soluble intercellular adhesion molecule-1, and soluble tumor necrosis factor-alpha receptors in young type 1 diabetic patients without clinical evidence of macrovascular complications.

  2001cited by this paper
• Evidence for increased peripheral production of tumor necrosis factor-alpha in advanced congestive heart failure.

  2001cited by this paper
• Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction.

  2000cited by this paper
• Chylomicron metabolism is markedly altered in systemic lupus erythematosus.

  2000cited by this paper
• Mechanisms of TNF-alpha-induced insulin resistance.

  1999cited by this paper
• Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus.

  1999cited by this paper
• Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines.

  1999cited by this paper
• Evidence for a role of tumor necrosis factor alpha in disturbances of triglyceride and glucose metabolism predisposing to coronary heart disease.

  1998cited by this paper
• Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study.

  1997cited by this paper
• Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies

  1997cited by this paper
• Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden.

  1997cited by this paper
• Platelet-activating factor and oxidized LDL induce immune activation by a common mechanism.

  1997cited by this paper
• Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity.

  1997cited by this paper
• Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus.

  1996cited by this paper
• The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus.

  1996cited by this paper
• Carotid intima-media thickness and plaque in borderline hypertension.

  1995cited by this paper
• Enhanced Expression of Vascular Matrix Metalloproteinases Induced In Vitro by Cytokines and in Regions of Human Atherosclerotic Lesions a

  1994cited by this paper
• Tumor necrosis factor in the pathogenesis of infectious diseases

  1993cited by this paper
• Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosus.

  1993cited by this paper
• Role of Cytokines in Inducing Hyperlipidemia

  1992cited by this paper
• Immune mechanisms in atherosclerosis.

  1989cited by this paper
• A phase I trial of intravenously-administered recombinant tumor necrosis factor-alpha in cancer patients.

  1988cited by this paper
• Measurement of systemic lupus erythematosus activity in clinical research.

  1988cited by this paper
• DYSLIPOPROTEINEMIA IN PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS

  1987cited by this paper
• Effect of short-term, low-dose corticosteroids on plasma lipoprotein lipids.

  1987cited by this paper
• Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man

  1985cited by this paper
• The hyperlipidemia of the nephrotic syndrome. Relation to plasma albumin concentration, oncotic pressure, and viscosity.

  1985cited by this paper
• Complement components, complement activation, and acute phase response in systemic lupus erythematosus.

  1984cited by this paper
• The 1982 revised criteria for the classification of systemic lupus erythematosus.

  1982cited by this paper
• The bimodal mortality pattern of systemic lupus erythematosus.

  1976cited by this paper
• Lipoprotein fractionation.

  1973cited by this paper

• CD40 blockade hampers IgG class-switch while enhancing Granzyme B production by transitional B cells.

  2025cites this paper
• Targeted Anti‐Inflammatory Therapy in Cardiovascular Events: Challenges and Opportunities

  2025cites this paper
• Serum lipid profile in systemic lupus erythematosus

  2025influential citation
• Systemic Lupus Erythematous: Gene Polymorphisms, Epigenetics, Environmental, Hormonal and Nutritional Factors in the Consideration of Personalized Therapy

  2024cites this paper
• Establishment and evaluation of a risk prediction model for coronary heart disease in primary Sjögren’s syndrome based on peripheral blood IL-6 and Treg percentages

  2024cites this paper
• Osteoimmunology: The effect of autoimmunity on fracture healing and skeletal analysis.

  2023cites this paper
• Cytokines in Systemic Lupus Erythematosus—Focus on TNF-α and IL-17

  2023cites this paper
• Altered expression of miR-125a and dysregulated cytokines in systemic lupus erythematosus: Unveiling diagnostic and prognostic markers

  2023cites this paper
• Cerebrolysin Attenuates Exacerbation of Neuropathic Pain, Blood-spinal Cord Barrier Breakdown and Cord Pathology Following Chronic Intoxication of Engineered Ag, Cu or Al (50–60 nm) Nanoparticles

  2023cites this paper
• Insulin Resistance and Diabetes Mellitus in Patients with Systemic Lupus Erythematosus.

  2022cites this paper
• Tumor necrosis factor‑α in systemic lupus erythematosus: Structure, function and therapeutic implications (Review).

  2022cites this paper
• Serum cytokine levels of systemic lupus erythematosus patients in the presence of concomitant cardiovascular diseases.

  2022cites this paper
• Multiplex Analysis of Serum Cytokine Profiles in Systemic Lupus Erythematosus and Multiple Sclerosis

  2022cites this paper
• Autoimmune Rheumatic Diseases: An Update on the Role of Atherogenic Electronegative LDL and Potential Therapeutic Strategies

  2021cites this paper
• Serum Metabolomic Signatures Can Predict Subclinical Atherosclerosis in Patients With Systemic Lupus Erythematosus.

  2021cites this paper
• State of the art review: coronary artery disease in patients with inflammatory bowel disease: mechanisms, prevalence, and outcomes

  2021cites this paper
• Degraded microarchitecture by low trabecular bone score is associated with prevalent vertebral fractures in patients with systemic lupus erythematosus

  2020cites this paper
• Systemic Tumor Necrosis Factor-Alpha Trajectories Relate to Brain Health in Typically Aging Older Adults.

  2019cites this paper
• 4th Meeting of Middle European Societies for Immunology and Allergology, 28-30 November 2019, Samorin, Slovakia.

  2019cites this paper
• Cardiovascular Disease in Systemic Lupus Erythematosus: recent data on epidemiology, risk factors and prevention.

  2019cites this paper
• Impact of Systemic Lupus Erythematosus on the Risk of Newly Diagnosed Hip Fracture: A General Population‐Based Study

  2019cites this paper
• TNF-α regulates microglial activation via the NF-κB signaling pathway in systemic lupus erythematosus with depression.

  2019cites this paper
• TNF-α and plasma albumin as biomarkers of disease activity in systemic lupus erythematosus

  2018cites this paper
• Inflammation and Trajectory of Renal Function in Community‐Dwelling Older Adults

  2018cites this paper
• Protective Effects of Hydroxychloroquine against Accelerated Atherosclerosis in Systemic Lupus Erythematosus

  2018cites this paper
• Systemic Inflammatory Response and Atherosclerosis: The Paradigm of Chronic Inflammatory Rheumatic Diseases

  2018cites this paper
• Cortical Bone Loss in a Spontaneous Murine Model of Systemic Lupus Erythematosus

  2018cites this paper
• Cardiovascular disease in systemic lupus erythematosus is associated with increased levels of biomarkers reflecting receptor-activated apoptosis.

  2018cites this paper
• Bone Disease in Connective Tissue Disease/Systemic Lupus Erythematosus

  2017cites this paper
• Dyslipidemia in systemic lupus erythematosus

  2017cites this paper
• Inflammatory diseases and bone fragility

  2017cites this paper
• Serum soluble tumour necrosis factor receptor-2 (sTNFR2) as a biomarker of kidney tissue damage and long-term renal outcome in lupus nephritis

  2017cites this paper
• Relation between serum inflammatory factors and lower-limb arteriosclerosis obliterans

  2017cites this paper
• Studies on Cardiovascular Disease in Systemic Lupus Erythematosus

  2017cites this paper
• Double positivity of the IgG isotype of both anticardiolipin and anti-β2gpI antibodies is associated with the highest number of vascular impairment parameters in patients with primary antiphospholipid syndrome: preliminary data

  2016cites this paper
• Lycopene reduces mortality in people with systemic lupus erythematosus: A pilot study based on the third national health and nutrition examination survey

  2016cites this paper
• Sucrose non-fermenting AMPK related kinase/Pentraxin 3 and DNA damage axis: a gateway to cardiovascular disease in systemic lupus erythematosus among Egyptian patients

  2016cites this paper
• Soluble Tumor Necrosis Factor Receptor 1 Is Associated with Glomerular Filtration Rate Progression and Incidence of Chronic Kidney Disease in Two Community-Based Cohorts of Elderly Individuals

  2015cites this paper
• [THE LEVELS OF OSTEOCALCIN AND PYRIDINOLINE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: THE RELATIONSHIP WITH STRUCTURAL AND FUNCTIONAL STATE OF BONE TISSUE AND COURSE OF THE DESEASE].

  2015cites this paper
• Atherosclerosis and Rheumatic Diseases

  2015cites this paper
• Bone Loss Triggered by the Cytokine Network in Inflammatory Autoimmune Diseases

  2015cites this paper
• Soluble tumor necrosis factor receptors and kidney dysfunction in elderly

  2015cites this paper
• Osteoporosis in Systemic Lupus Erythematosus - Correlations with Disease Activity and Organ Damage

  2015cites this paper
• Accelerated vascular disease in systemic lupus erythematosus: role of macrophage.

  2015cites this paper
• Systemic lupus erythematosus and fractures

  2015cites this paper
• The Role of IL-1β in the Bone Loss during Rheumatic Diseases

  2015cites this paper
• Novel Inflammatory Markers in Hyperlipidemia: Clinical Implications.

  2015cites this paper
• Soluble TNF receptors and kidney dysfunction in the elderly.

  2014cites this paper
• The role of n - 6 and n - 3 polyunsaturated fatty acids in the manifestation of the metabolic syndrome in cardiovascular disease and non-alcoholic fatty liver disease.

  2014cites this paper
• TNF/TNFR: drug target for autoimmune diseases and immune-mediated inflammatory diseases.

  2014cites this paper
• Osteoporosis and rheumatic diseases.

  2014cites this paper
• Cardiovascular Disease and Immune Mechanisms in Systemic Lupus Erythematosus

  2014cites this paper
• Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus

  2014cites this paper
• A network-based analysis of the types of coronary artery disease from traditional Chinese medicine perspective: potential for therapeutics and drug discovery.

  2014cites this paper
• Prevention and management of co-morbidities in SLE.

  2014cites this paper
• Low Levels of Antibodies Against Oxidized but not Nonoxidized Cardiolipin and Phosphatidylserine Are Associated with Atherosclerotic Plaques in Systemic Lupus Erythematosus

  2013cites this paper
• Roles of Apolipoprotein E (ApoE) and Inducible Nitric Oxide Synthase (iNOS) in Inflammation and Apoptosis in Preeclampsia Pathogenesis and Progression

  2013cites this paper
• Atherosclerosis in Systemic Lupus Erythematosus

  2013cites this paper
• Cardiovascular risk in pediatric-onset rheumatological diseases

  2013cites this paper
• Th17/Treg imbalance induced by increased incidence of atherosclerosis in patients with Systemic Lupus Erythematosus (SLE)

  2013cites this paper
• Premature coronary heart disease in SLE: can we prevent progression?

  2013cites this paper
• Plasmacytoid dendritic cells: biomarkers or potential therapeutic targets in atherosclerosis?

  2013cites this paper
• Osteoporosis and fractures in systemic lupus erythematosus

  2012cites this paper
• CARDIOVASCULAR INVOLVEMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS

  2012cites this paper
• Inflammatory Rheumatic Disorders and Bone

  2012cites this paper
• Accelerated atherosclerosis in patients with SLE—mechanisms and management

  2012cites this paper
• The impact of obesity in systemic lupus erythematosus on disease parameters, quality of life, functional capacity and the risk of atherosclerosis

  2012cites this paper
• Oils rich in alpha‐linolenic acid independently protect against characteristics of fatty liver disease in the delta‐6‐desaturase null mouse

  2012cites this paper
• Cardiovascular risk assessment in patients with systemic lupus erythematosus: practical aspects

  2011cites this paper
• The interplay of inflammation and cardiovascular disease in systemic lupus erythematosus

  2011cites this paper
• The problem of accelerated atherosclerosis in systemic lupus erythematosus: Insights into a complex co-morbidity

  2011cites this paper
• Relevance of urocortins to cardiovascular disease.

  2011cites this paper
• Particular human leukocyte antigen alleles are associated with biochemical traits in the Japanese population.

  2011cites this paper
• The interplay of infl ammation and cardiovascular disease in systemic lupus erythematosus

  2011cites this paper
• Accelerated Atherosclerosis in Systemic Lupus Erythematosus: Role of Proinflammatory Cytokines and Therapeutic Approaches

  2010cites this paper
• Regulation of high‐density lipoprotein by inflammatory cytokines: establishing links between immune dysfunction and cardiovascular disease

  2010cites this paper
• INNATE MECHANISMS REGULATING PERIPHERAL B CELL TOLERANCE

  2010cites this paper
• Genetically Determined Serum Levels of Mannose-Binding Lectin Correlate Negatively with Common Carotid Intima-Media Thickness in Systemic Lupus Erythematosus

  2010cites this paper
• Review article: systemic lupus erythematosus: a review for anesthesiologists.

  2010cites this paper
• Increased prevalence of vulnerable atherosclerotic plaques and low levels of natural IgM antibodies against phosphorylcholine in patients with systemic lupus erythematosus

  2010influential citation
• Low level natural antibodies against phosphorylcholine: a novel risk marker and potential mechanism in atherosclerosis and cardiovascular disease.

  2010cites this paper
• Management of cardiovascular complications in systemic lupus erythematosus.

  2010cites this paper
• Effects of inflammation on cholesterol metabolism: Impact on systemic lupus erythematosus

  2009cites this paper
• Dyslipidaemia and lipoprotein pattern in systemic lupus erythematosus (SLE) and SLE‐related cardiovascular disease

  2009cites this paper
• Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study

  2009cites this paper
• Dyslipidaemia in rheumatoid arthritis: the role of inflammation, drugs, lifestyle and genetic factors.

  2009cites this paper
• THE FUNCTIONAL REGULATION OF FCRN EXPRESSION AND FCRN-MEDIATED ANTIGEN PRESENTATION

  2009cites this paper
• Natural Antibodies against Phosphorylcholine in Cardiovascular Disease

  2009cites this paper
• Cardiovascular risk assessment and treatment in systemic lupus erythematosus.

  2009cites this paper
• Atherosclerosis risk factors in systemic lupus erythematosus

  2009cites this paper
• A STAT4 risk allele is associated with ischaemic cerebrovascular events and anti-phospholipid antibodies in systemic lupus erythematosus

  2009cites this paper
• Endothelial function and markers of endothelial activation in relation to cardiovascular disease in systemic lupus erythematosus

  2008influential citation
• Atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus.

  2008cites this paper
• Increased risk of vascular events in systemic lupus erythematosus: is arterial stiffness a predictor of vascular risk?

  2008cites this paper
• Systemic lupus erythematosus and cardiovascular disease

  2008cites this paper
• Coronary risk in autoimmune rheumatological diseases: an unfolding saga and perspective for Asian Indians

  2008cites this paper
• Natural antibodies against phosphorylcholine as potential protective factors in SLE.

  2008cites this paper
• The TNFα locus is altered in monocytes from patients with systemic lupus erythematosus

  2007cites this paper
• Lupus Eritematoso Sistémico

  2007cites this paper
• NF-κB Signaling Regulates Functional Expression of the MHC Class I-Related Neonatal Fc Receptor for IgG via Intronic Binding Sequences1

  2007cites this paper